Product Reports Resources Pricing Login Book a demo
Zavain Dar
Person deep dive

Zavain Dar

#25 2026 Strebulaev–Jackson Venture Ranking, emerging firms

Zavain Dar was a general partner at Lux Capital and co-founded Dimension in 2022 to invest where software meets biology. He backed Recursion Pharmaceuticals at its 2016 Series A and still sits on its board; it listed on Nasdaq in 2021 in a $436M IPO.

Founded
Achira, Dimension, FountainHop
Education
Stanford University, University of Oxford, Stanford University

Track record

Investments Zavain Dar is best known for, with what became of them.

Dimension

FirmDimension
Founded2022
Based inNew York
Funds$350M in 2022, $500M in 2024 and $800M in 2026; $1.65B under management
FocusStartups at the intersection of life sciences and computing

Career

  1. About 2013Worked at Innovation Endeavors with his future co-founder Nan Li.
  2. 2016Invested in Recursion's Series A while at Lux Capital.
  3. 2022Left Lux in March with Adam Goulburn and Nan Li; Dimension closed a $350M first fund in December.
  4. 2024Closed a $500M second fund, above its $400M target.
  5. 2026Closed an $800M third fund in July.

Sources: Fortune: Dimension launches (2023) · TechCrunch: Dimension raises $500M second fund · BioPharma Dive: Dimension third fund · Dealroom: Zavain Dar. Rank: 2026 Strebulaev–Jackson Venture Ranking.

Investments 7

Companies backed, as recorded by Dealroom. Highest company valuations first.

Companies founded

Currently

Active roles, board seats and partnerships.

Work history

Past roles by Dealroom records.

Education

Stanford University
Msc · Computer Science · 2010 – 2012
University of Oxford
2007 – 2008
Stanford University
Bachelor · 2006 – 2010
← All people